ES2161782T3 - Metodo de inhibicion de formacion de oxido nitrico. - Google Patents

Metodo de inhibicion de formacion de oxido nitrico.

Info

Publication number
ES2161782T3
ES2161782T3 ES94926572T ES94926572T ES2161782T3 ES 2161782 T3 ES2161782 T3 ES 2161782T3 ES 94926572 T ES94926572 T ES 94926572T ES 94926572 T ES94926572 T ES 94926572T ES 2161782 T3 ES2161782 T3 ES 2161782T3
Authority
ES
Spain
Prior art keywords
nitric oxide
inhibition
training
inhibit
nitrive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94926572T
Other languages
English (en)
Inventor
Joseph P Williamson
John A Corbett
Michael L Mcdaniel
Ronald G Tilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of ES2161782T3 publication Critical patent/ES2161782T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE MUESTRA UN METODO PARA INHIBIR LA FORMACION DE OXIDO NITRICO EN MAMIFEROS DE SANGRE CALIENTE AFECTADOS POR ENFERMEDADES INFLAMATORIAS CRONICAS O AGUDAS QUE SUPONE LA ADMINISTRACION A LOS MISMOS DE UNA CANTIDAD EFECTIVA PARA INHIBIR EL OXIDO NITRICO DE GUANIDINAS AMINO SUSTITUTIVAS, 1,1-DIMETIL- O METIL-.
ES94926572T 1993-08-24 1994-08-23 Metodo de inhibicion de formacion de oxido nitrico. Expired - Lifetime ES2161782T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/110,915 US5358969A (en) 1991-12-16 1993-08-24 Method of inhibiting nitric oxide formation

Publications (1)

Publication Number Publication Date
ES2161782T3 true ES2161782T3 (es) 2001-12-16

Family

ID=22335627

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94926572T Expired - Lifetime ES2161782T3 (es) 1993-08-24 1994-08-23 Metodo de inhibicion de formacion de oxido nitrico.

Country Status (10)

Country Link
US (1) US5358969A (es)
EP (1) EP0771195B1 (es)
JP (1) JPH09502703A (es)
AT (1) ATE202929T1 (es)
AU (1) AU688370B2 (es)
CA (1) CA2169481C (es)
DE (1) DE69427711T2 (es)
ES (1) ES2161782T3 (es)
NZ (1) NZ273167A (es)
WO (1) WO1995005811A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733524A (en) * 1984-03-19 1998-03-31 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5700447A (en) * 1992-05-21 1997-12-23 The Picowder Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5733933A (en) * 1984-03-19 1998-03-31 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5801200A (en) * 1984-03-19 1998-09-01 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5710181A (en) * 1991-12-16 1998-01-20 Washington University Inhibition of nitric oxide formation in inflammatory bowel disease
US5837738A (en) * 1991-12-16 1998-11-17 Washington University Method of inhibiting nitric oxide formation
WO1996002245A1 (en) * 1994-07-14 1996-02-01 The Wellcome Foundation Limited Nitric oxide synthase inhibitors for inhibiting the production of airway mucus
US5583101A (en) * 1994-07-15 1996-12-10 Harvard College Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5780513A (en) * 1996-08-22 1998-07-14 Washington University Method of inhibiting the release of bioactive IL-1
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
WO1998033379A1 (en) * 1997-02-04 1998-08-06 The General Hospital Corporation A novel method for treating epidermal or dermal conditions
PL346860A1 (en) 1998-09-08 2002-03-11 Monsanto Co Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
DE69919403T2 (de) 1998-12-01 2005-09-08 The University Of Kentucky Research Foundation Verwendung von nikotinsäurederivate zur behandlung von dna-schäden bei hautzellen
AU2001265151A1 (en) * 2000-05-31 2001-12-11 Encelle, Inc. Method of stimulating hair growth

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757219A (fr) * 1969-10-13 1971-03-16 Interstop Ag Fermeture a tiroir de decharge pour des cuves de coulee de metaux
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
US5218001A (en) * 1984-03-19 1993-06-08 The Rockefeller University Inhibitors of the advanced glycosylation of proteins and methods of use therefor
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
US4983604A (en) * 1987-11-13 1991-01-08 The Rockefeller University Inhibitors of nonenzymatic cross-linking
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US4870210A (en) * 1987-12-18 1989-09-26 American Home Products Corporation Aminoguanidine derivative as anti-inflammatory agents
DE4034722A1 (de) * 1990-07-27 1992-04-30 Mannesmann Ag Verwendung eines eingiesssystem
CA2085399A1 (en) * 1991-12-16 1993-06-17 Joseph Robert Williamson Method for inhibiting nitric oxide formation
US5246970A (en) * 1991-12-16 1993-09-21 Washington University Method of inhibiting nitric oxide formation

Also Published As

Publication number Publication date
DE69427711D1 (de) 2001-08-16
JPH09502703A (ja) 1997-03-18
AU7636994A (en) 1995-03-21
AU688370B2 (en) 1998-03-12
EP0771195A1 (en) 1997-05-07
ATE202929T1 (de) 2001-07-15
DE69427711T2 (de) 2002-05-08
WO1995005811A1 (en) 1995-03-02
EP0771195B1 (en) 2001-07-11
CA2169481A1 (en) 1995-03-02
NZ273167A (en) 1999-08-30
US5358969A (en) 1994-10-25
CA2169481C (en) 1999-11-16
EP0771195A4 (en) 1997-12-29

Similar Documents

Publication Publication Date Title
ES2161782T3 (es) Metodo de inhibicion de formacion de oxido nitrico.
AR010348A1 (es) Cetobenzamidas, su utilizacion y composicion farmeceutica que las contienen
DK0735868T3 (da) Anvendelse af ikke-steroide cyclooxygenaseinhibitorer til fremstilling af et medikament til behandling af forhøjet intrakul
PT82724B (pt) Processo para a preparacao de derivados de difluoro cetona-peptideos e de uma composicao farmaceutica que os contem
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
MX9603930A (es) Inhibicion del crecimiento del pelo.
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
ES2169105T3 (es) Agentes antitromboticos tripeptidicos.
MX9308199A (es) Inhibidores de enzima.
ES2120993T3 (es) Agentes antitromboticos.
ES2122283T3 (es) Inhibicion del crecimiento capilar.
ES2008414A6 (es) Metodo y composicion para combatir enfermedades de secciones de poda en plantas
ES2042737T3 (es) Un procedimiento para la preparacion de un glucosido de antraciclina.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
ES2157252T3 (es) Aplicacion del riluzol en el tratamiento del neuro-sida.
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
ES2171590T3 (es) Composicion farmaceutica para el tratamiento de rinitis agudas, que contiene un simpatomimetico y pantotenol y/o acido pantotenico.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
ES548161A0 (es) Procedimiento para el tratamiento electrostatico de sales brutas de potasio,molidos,que contienen kieserita
AR005549A1 (es) Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 771195

Country of ref document: ES